Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06632249

Effects of HIIT VR Exergame on Attention and Executive Function in Young People With ADHD

The goal of this clinical trial is to learn if the "Move Sapiens" exergame in Virtual Reality (VR), incorporated with a short model of High-Intensity Interval Training (HIIT), works as an intervention tool for adolescents with Attention-Deficit Hyperactivity/Disorder (ADHD). It will also assess the safety and effectiveness of this intervention.

The main questions it aims to answer are: Does interacting with HIIT "Move Sapiens®" in VR improve attention and executive function in adolescents with ADHD? Does this intervention reduce other symptoms such as sleep problems and anxiety? Researchers will compare the HIIT VR exergame to a control condition.

Participants will: Engage with "Move Sapiens®" in VR (intervention group) or participate in a control condition with an adapted version of the exergame without physical exercise (control group) (five times a week for 4 weeks). Visit the clinic for assessments and tests. The analysis will involve comparing group means using a mixed model and calculating effect sizes with Cohen's d to determine the clinical relevance of the results

Recruiting

Interested in participating?

Request Info

Key information

Age range

12 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil

Loading trial locations.

About this study

Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity, affecting 3-5% of the global school-age population. Literature data show that high-intensity interval training (HIIT) is a potential intervention for ADHD inattentive symptoms and cognitive functioning deficits. These neuromodulatory effects have great potential to enhance neural plasticity and improve the executive functions of patients with ADHD. Furthermore, virtual reality (VR) can increase motivation for general activities, being a possible interesting tool, especially for people with ADHD.

Therefore, this study will investigate the potential of the 'Move Sapiens®' exergame in VR as an intervention tool for adolescents with ADHD. The primary objective is to assess whether interacting with 'Move Sapiens®' in VR can induce observable improvements in executive function and attention, a secondary objective is investigating a possible reduction in symptoms such as sleep problems and anxiety. Data will be obtained through validated questionnaires, in evaluation sessions conducted by clinicians and neuropsychologist, before and after the intervention. Ninety-eight participants, aged 12 to 17 with ADHD, will be randomly allocated in two groups that will interact with two versions of the VR 'Move Sapiens®' (with and without HIIT) during 20 sessions over 4 weeks. The four initial sessions and the last session will be performed in the laboratory. In these sessions, heart hate will also be monitored. Other sessions will be done at home with remote supervision. In all sessions, the game score will be monitored. The experimental group will practice the exergame, which incorporates a short model of HIIT, consisting of 12 cycles that include 16 seconds of maximum effort followed by 20 seconds of rest (total: 7 minutes and 12 seconds). In the control group, participants will engage in an adapted version of the Move Sapiens exergame without physical exercise, interacting through the joystick. This randomized clinical trial will be conducted in two centres: the Hospital de Clínicas de Porto Alegre (HCPA), and the Centro de Escola de Especialidades Médicas (CEEM - UniEduk/UniMax).

Furthermore, in a small convenience subsample of 30 participants (15 intervention and 15 control group) from the Porto Alegre-RS, we will explore a possible biological mechanism ("brain signature") associated with improved attention, detectable by fMRI, suggesting potential changes in brain function detectable through neuroimaging.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • participants with diagnosis of ADHD according to DSM-5;
  • age between 12 and 17 years;
  • no prior use of ADHD medication or have not been using ADHD medication for at least one month.

Exclusion criteria

  • participants with conditions and comorbidities that prevent the execution of HIIT in VR, such as severe additional psychiatric and physical conditions and a history of seizures;
  • inattention score below 12 on the SNAP-IV inattention subscale;
  • IQ below 70;
  • recreationally active people who engage in intense, systematic physical activity more than two times a week.

For the MRI assessment, the following exclusionary criteria are added:

  • participants with non-compatible aneurysm clips, cochlear implants, pacemakers, metal fragments in the body or eyes, or non-removable piercings;
  • internal metal residues that interfere with image acquisition and analysis;
  • severe claustrophobia;
  • respiratory difficulties that prevent cooperation;
  • inability to remain still due to hyperactivity;
  • body weight and size exceeding device limits;
  • excessive involuntary movement;
  • anatomical abnormalities.

Treatment and study plan

Practice with the virtual reality game

Other

4 weeks of practice with the virtual reality game, totalling 20 sessions, 5 supervised in the laboratory and 15 at home with remote monitoring.

Other names: Move Sapiens®

Primary outcomes

  1. Inattention total score

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    SNAP-IV will be used to assess inattention scores. Responses to 9 items aligned with DSM-5 Inatention criteria will be collected from parents using a 4-point Likert scale.

  2. Inhibibitory Control

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    Inhibitory control will be assessed with a computerized Go/No Go task. Number of Comission Errors corrected by age will be the outcome used.

Secondary outcomes

  1. Verbal Working Memory

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    The Digit Symbol Test evaluates verbal working memory and the outcome will be the scaled score for the backward condition.

  2. Spatial Working Memory

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    The Spatial Span Task is designed based on the Corsi Block, it evaluates spatial working memory. The outcome is the number of correct responses corrected by age for the backward condition

  3. Cognitive Flexibility

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    Trail Making Test will be used to evaluate cognitive flexibility. The outcome will be the time to complete B form corrected by age.

  4. Reaction Time

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    The Two-Choice Reaction Time task assesses processing speed and the score used will be the average reaction time corrected by age.

  5. Sleep quality

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    To assess sleep quality, we will use the Pittsburgh Sleep Quality Index (PSQI). This instrument is a self-administered questionnaire that investigates sleep quality over a one-month interval. The PSQI focuses on seven components: sleep latency, duration, efficiency, disturbances, use of sleep medication, daytime dysfunction, and subjective sleep quality. A higher total score on the PSQI indicates poorer sleep quality.

  6. Anxiety symptoms

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    To assess anxiety symptoms, we will use the 7-item Generalized Anxiety Disorder Scale (GAD-7). Participants will report the frequency of their anxiety symptoms over the past two weeks using a 4-point Likert scale, aiding in identifying and assessing the severity of generalized anxiety disorder.

  7. Impulsivity and attention

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    The MOXO-continuous performance test measures four domains, including attention, timeliness, hyperactivity and impulsivity. We will use the Impulsivity z-score to assess impulsivity.

Other outcomes

  1. Functional Magnetic Resonance Imaging (fMRI)

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    In a small convenience subsample from the Porto Alegre-RS group, fifteen participants from the intervention group and fifteen participants from the control group who provide informed consent (ICF) will have functional neuroimaging collected at the Brain Institute (InsCer) of PUCRS at baseline (T0) before the intervention, and within 7 days after the interventions (T1). The image acquisition time will be 40 minutes, and both resting-state fMRI and task-based fMRI images will be collected, using attention and inhibitory control tasks.

  2. Heart Rate

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    Heart rate (HR) data will be used as an objective measure of exercise intensity. HR recording will be evaluated during the 5 in-person training sessions, measuring the average and maximum HR (average HR and HRmax). A heart rate monitor (Polar H10) will be used for this purpose. Heart rate recovery (HRR: Δ bpm) will be measured during 5 minutes of recovery, and the average will be calculated every 5 seconds. Heart rate variability (HRV) will also be recorded (Polar beat app) and analysed using the Kubios software, in rest state and during a cognitive task.

  3. Participants' experiences in the game

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    The Game Experience Questionnaire will explore participants 'experiences related to the game, covering dimensions such as immersion, flow, and affect.

  4. Discomfort associated with the use of virtual reality

    Time frame: Pre intervention (baseline) and post intervention (4th week)

    To assess discomfort associated with the use of virtual reality in our project, we will use the Simulator Sickness Questionnaire (SSQ). The 16-item questionnaire measures the incidence and severity of motion sickness symptoms in three categories: nausea, oculomotor issues, and disorientation.

Study contacts

Contact information is provided by the study sponsor or research team.

Luis Augusto Rohde, PhD

CONTACT

[email protected]

+55 51 33598094

Pietro Merola, PhD

CONTACT

[email protected]

+55 51 33598094

Sponsors and collaborators

Lead sponsor

Hospital de Clinicas de Porto Alegre

Other

Collaborators

  • Centro de Inovação em Saúde Mental (CISM)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Grupo UniEDUK
  • University of Sao Paulo

Registry information

Official study title

Effects of HIIT VR Exergame on Attention and Executive Function in Young People With ADHD: A Randomized Clinical Trial With 'Move Sapiens®'

Acronym: VRADHD

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Oct 9, 2024
Registry last updated
Oct 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.